Login

Consolidated Statements of Assets and Liabilities

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Assets
Investments at fair value
Non-control/non-affiliate investments
Non-control affiliate investments
Total investments at fair value
Forward contracts, at fair value (cost of $0 and $0, respectively)
Derivatives, at fair value (cost of $0 and $0, respectively)
Cash and cash equivalents
Restricted cash
Interest and dividends receivable
Prepaid expenses
Receivable for unsettled trades
Prepaid expenses and other assets
Total assets
Liabilities
Credit facility (net of deferred financing costs of $1,552 and $1,361, respectively)
Payable for unsettled trades
Due to affiliate
Management fees payable
Incentive fees payable
Interest expense payable
Directors' fees payable
Accounts payable and other liabilities
Distribution payable
Total liabilities
Net Assets
Common stock, $0.001 par value, 1,000,000,000 shares authorized; 5,296,262 and 5,240,672 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Capital in excess of par
Total distributable (loss) earnings
Total net assets
Total liabilities and net assets
Net asset value per share

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support